Business
Glenmark Pharmaceuticals Limited Press Release Jul 28 2026
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 28, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials".
About this update from Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 28, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials". View Attachment
View stock analysis, news, and events for Glenmark Pharmaceuticals Limited